価格表

在庫・価格 : 2024年05月07日 06時13分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-FUS, Rabbit-Poly <Anti-ALS6>
データシート
HPA008784 AABアトラスアンチボディーズ
Atlas Antibodies AB
100 μl ¥96,000
(未発注)
追加

在庫・価格 : 2024年05月07日 06時13分 現在

Anti-FUS, Rabbit-Poly <Anti-ALS6>

  • 商品コード:HPA008784
  • メーカー:AAB
  • 包装:100μl
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Neumann M et al. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol. 2009 Nov;118(5):605-16
Neumann M et al
2009/01/01
PubMed
2 Neumann M et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009 Nov;132(Pt 11):2922-31
Neumann M et al
2009/01/01
PubMed
3 Munoz DG et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol. 2009 Nov;118(5):617-27
Munoz DG et al
2009/01/01
PubMed
4 Seelaar H et al. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J. Neurol. 2010 May;257(5):747-53
Seelaar H et al
2010/01/01
PubMed
5 Urwin H et al. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010 Jul;120(1):33-41
Urwin H et al
2010/01/01
PubMed
6 Kino Y et al. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. Nucleic Acids Res. 2011 Apr;39(7):2781-98
Kino Y et al
2011/01/01
PubMed
7 Dobson-Stone C et al. Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: genetic, clinical and neuropathological analysis. Acta Neuropathol. 2013 Apr;125(4):523-33
Dobson-Stone C et al
2013/01/01
PubMed
8 . ;

PubMed
9 Lashley T et al. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain 2011 Sep;134(Pt 9):2548-64
Lashley T et al
2011/01/01
PubMed
10 Neumann M et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 2011 Sep;134(Pt 9):2595-609
Neumann M et al
2011/01/01
PubMed
11 Pikkarainen M et al. Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry. Cerebellum 2011 Dec;10(4):720-31
Pikkarainen M et al
2011/01/01
PubMed
12 Snowden JS et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012 Mar;135(Pt 3):693-708
Snowden JS et al
2012/01/01
PubMed
13 Qiu H et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J. Clin. Invest. 2014 Mar;124(3):981-99
Qiu H et al
2014/01/01
PubMed
  • No.: 1
  • 文献情報:
    Neumann M et al. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol. 2009 Nov;118(5):605-16
    Neumann M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Neumann M et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009 Nov;132(Pt 11):2922-31
    Neumann M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Munoz DG et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol. 2009 Nov;118(5):617-27
    Munoz DG et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Seelaar H et al. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J. Neurol. 2010 May;257(5):747-53
    Seelaar H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Urwin H et al. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010 Jul;120(1):33-41
    Urwin H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Kino Y et al. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. Nucleic Acids Res. 2011 Apr;39(7):2781-98
    Kino Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Dobson-Stone C et al. Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: genetic, clinical and neuropathological analysis. Acta Neuropathol. 2013 Apr;125(4):523-33
    Dobson-Stone C et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    . ;

  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Lashley T et al. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain 2011 Sep;134(Pt 9):2548-64
    Lashley T et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Neumann M et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 2011 Sep;134(Pt 9):2595-609
    Neumann M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Pikkarainen M et al. Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62/sequestosome immunohistochemistry. Cerebellum 2011 Dec;10(4):720-31
    Pikkarainen M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Snowden JS et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012 Mar;135(Pt 3):693-708
    Snowden JS et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Qiu H et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J. Clin. Invest. 2014 Mar;124(3):981-99
    Qiu H et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed